Synergy Laboratories Taps SOPHiA GENETICS Technology for New

The New Solution uses SOPHiA DDM and aims to Benefit Cancer Research, Clinical Studies and Patient Care SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today

Related Keywords

Alabama , United States , Dennis Riedl , Nick Puleo , Joseph Cohil , Ken Freedman , Exchange Commission , Cancer Research , Instagram , Research Use , Twitter , Nasdaq , New Solution , Benefit Cancer Research , Clinical Studies , Synergy Oncology , Synergy Laboratories , Hereditary Cancers Solution , Chief Revenue Officer , Artificial Intelligence , Hereditary Cancers , Research Use Only , Looking Statements , Synergy , Laboratories , Caps , Sophia , Enetics , Technology , Dancer , Profiling , Solution ,